New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 17, 2011
09:11 EDTAGNAllergan's Botox migraine should be well received, says Susquehanna
Susquehanna is raising its forecast for Allergan's Botox sales following an investor lunch with an expert neurologist. The firm cited better than expected efficacy, the target market, and potential for a high level of acceptance and retention rates. Shares are Positive rated with a $93 price target.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
17:34 EDTAGNActavis registration statement for Allergan acquisition declared effective
Subscribe for More Information
January 21, 2015
12:30 EDTAGNGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use